John Carney, MD
Dermatology · Little Rock, ARNPI 1699746370
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $491 of the $581 with a category attached, or 84.5%. 7 manufacturers reported payments, led by Paratek Pharmaceuticals, Inc. at 38.2% of the total. Reporting peaked in 2024 at $299 and has fallen 91.7% since, to $25 in 2025. That places this record below the midpoint for dermatology clinicians in AR, where the typical reported total is $3,769.
Across 15 payments — averaging $38.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Paratek Pharmaceuticals, Inc.$222
- Kerecis Limited$195
- Johnson & Johnson$90
- Dermavant Sciences, Inc.$30
- Pfizer$18
- Regeneron Healthcare Solutions, Inc.$13
- plus $12 from 1 others
What the payments were for
- Food & beverage$49185%
- Education$9015%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Paratek Pharmaceuticals, Inc. | 6 | $222 |
| Kerecis Limited | 3 | $195 |
| Johnson & Johnson | 1 | $90 |
| Dermavant Sciences, Inc. | 2 | $30 |
| Pfizer | 1 | $18 |
| Regeneron Healthcare Solutions, Inc. | 1 | $13 |
| Sanofi-aventis U.S. LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$581 in reported general payments places this provider in the 25th percentile of 75 dermatology providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 23 | $1,010 |
| Fluorouracil | 14 | $819 |
| Betamethasone Dipropionate | 17 | $810 |
| Clindamycin Phosphate | 15 | $673 |
| Ketoconazole | 33 | $488 |
| Doxycycline Hyclate | 24 | $210 |
| Clindamycin Hcl | 15 | $130 |
| Triamcinolone Acetonide | 20 | $113 |
| Prednisone | 12 | $41 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Little Rock
- Brian WayneLittle Rock$13K
- Andrea MabryLittle Rock$12K
- Thomas ManningLittle Rock$11K
- Marla WirgesLittle Rock$11K
- Kayla MohrLittle Rock$9K
- Gregory DwyerLittle Rock$8K
- Gunnar GibsonLittle Rock$7K
- Garrett NelsonLittle Rock$6K
- Jacey GuthrieLittle Rock$6K
- Rebecca LeeLittle Rock$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.